Suggestions
Lori Englebert
Senior Vice President, Commercial and Business Development at Axsome Therapeutics, Inc.
Professional Background:
Lori Englebert is a seasoned leader in commercial and business development, with a wealth of experience that spans multiple sectors within the biopharmaceutical industry. Currently serving as the Senior Vice President of Commercial and Business Development at Axsome Therapeutics, Inc., Lori has been instrumental in advancing the company's goals through strategic initiatives and business growth programs. Her impressive trajectory at Axsome Therapeutics demonstrates both her expertise and dedication to driving success in a highly competitive environment. Prior to her current role, Lori held several significant positions at Axsome, including Vice President and Executive Director, where she significantly contributed to the commercial strategies that have propelled the company forward in the innovative field of neuroscience.
Career Journey at Axsome Therapeutics:
Since joining Axsome Therapeutics, Lori has played a pivotal role in shaping the company's business development and commercial strategies. Her progressive advancement through various leadership roles from Executive Director to Senior Vice President illustrates not only her strategic acumen but also her capacity to lead teams effectively in delivering results. Under her guidance, Axsome has successfully navigated complex market dynamics, capitalizing on opportunities that have enhanced its competitive edge and fostered sustainable growth. Lori's vision and leadership have ensured that Axsome Therapeutics maintains its reputation as a leader in addressing numerous unmet medical needs in the psychiatric and neurological space.
Contributions to Amgen:
Before her impactful journey at Axsome, Lori was a formidable force at Amgen, one of the world's leading biotechnology companies. Her tenure at Amgen spanned various strategic roles, including Executive Director for Global Marketing Lead, Hematology/Oncology, and Director of Neuroscience Commercial Strategic Planning. Lori's ability to innovate and execute commercial strategies that resonate with healthcare providers and patients has been a hallmark of her career at Amgen. In her positions there, she emphasized the importance of aligning brand strategies with patient needs, which resulted in successful product launches and market penetration in the hematology and oncology areas.
Lori's role as Director, Global Brand Lead, Inflammation and Bone exemplifies her breadth of expertise across therapeutic areas, showcasing her versatility in managing complex commercial landscapes and coordinating cross-functional teams to achieve ambitious goals. In addition, she served as Director of Corporate Strategy & Business Development, where she played a critical role in identifying and facilitating key strategic partnerships and collaborations that have fortified Amgen's position in the biotechnology market.
Earlier Career Development:
Lori's professional background extends further into her earlier career experiences which laid the groundwork for her tremendous success. With a strong foundation in operations and strategy, her roles have included positions such as Senior Manager, International Commercial Business Strategy at Amgen and Portfolio Manager in Commercial Real Estate at First Tennessee Bank. Each of these roles allowed her to cultivate her analytical skills, deepen her understanding of market dynamics, and develop strategic frameworks that would serve her well in her subsequent leadership positions.
Additionally, Lori gained valuable experience in global business planning and analytics at Novartis, which equipped her with analytical skills required to support high-level decision-making processes. She commenced her career in financial services at Bloomberg LP, where she honed her capabilities in business development and strategic sales, establishing a robust skill set that would become intrinsic to her roles in the biotechnology sector.
Education and Achievements:
Lori Englebert holds an MBA from Wake Forest University School of Business, where she honed her business acumen and developed a strategic mindset tailored for the ever-evolving landscapes of healthcare and biopharmaceutical marketing. Her educational background was complemented by a Bachelor of Arts degree from Wake Forest University, establishing a strong academic foundation that has been vital throughout her career.
Throughout her career, Lori has been recognized for her contributions within the commercial sector. Her ability to cultivate collaborative relationships, foster innovation, and implement effective strategies has established her as a respected leader in the industry. Lori’s insight into market trends and customer needs has been pivotal in driving initiatives that prioritize patient access to life-changing therapies.
Notable Achievements:
- Instrumental in the successful launch of multiple innovative therapies at both Axsome Therapeutics and Amgen, focusing on addressing critical healt
